Stocktoria

Ceribell, Inc. CBLL

Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2024-10-11 · LEI

Ceribell, Inc. statistics & valuation

Market cap$758.1M
P / S8.5×
P / B4.9×
Net margin-60.0%
Return on equity-34.4%
FCF margin-46.7%
Return on capital-33.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-65.10% -61.80% -60.00% 202320242025
Gross margin (%)
84.40% 86.70% 87.90% 202320242025
Operating margin (%)
-66.40% -60.70% -65.60% 202320242025
Return on equity (%)
-21.20% -34.40% 202320242025
Shares outstanding
5.4M 35.9M 37.5M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-50.00% -17.90% -27.30% 202320242025
Free cash flow margin (%)
-66.60% -55.60% -46.70% 202320242025
Debt / equity (×)
202320242025
EPS ($)
-$5.56 -$3.39 -$1.46 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Gross margin87.9%86.7%84.4%
Operating margin-65.6%-60.7%-66.4%
Net margin-60.0%-61.8%-65.1%
FCF margin-46.7%-55.6%-66.6%
Return on assets-27.3%-17.9%-50.0%
Return on equity-34.4%-21.2%26.2%
Current ratio9.7316.732.41

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.